Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
Pharmaceutical giant Eli Lilly has launched its innovative tirzepatide injection, Mounjaro, in Libya, offering a new dual-acting treatment to address the country’s escalating public health crisis of obesity and type 2 diabetes. Eli Lilly has launched Mounjaro, the tirzepatide injection,…
New research suggests that elevated cortisol may impair the effectiveness of GLP-1 incretin therapies in some patients, prompting calls for more nuanced diagnostic approaches to optimise diabetes treatment outcomes. GLP-1 drugs have become best known for weight loss, but they…
While GLP-1 prescription drugs can aid in appetite control and broader health improvements, their use for weight management demands careful consideration of individual health profiles, potential side effects, and long-term planning beyond social media trends. Choosing a GLP-1 medicine for…
A recent study from Dubai reveals a high prevalence of vitamin D insufficiency among children and adolescents with type 1 diabetes, raising concerns about potential impacts on metabolic control and bone health in the region. A new study from Mohammed…
A normal blood glucose reading does not necessarily rule out prediabetes, as HbA1c offers a longer-term view of blood sugar trends. Experts emphasise using both tests for accurate diagnosis. A blood glucose reading of 81 mg/dL and an HbA1c result…
The U.S. FDA has authorised wider use of Tzield for children as young as 1 with stage 2 type 1 diabetes, offering potential to delay insulin treatment and highlight the importance of early diagnosis. The U.S. Food and Drug Administration…
An increasing number of police forces across the UK are equipping officers with naloxone and basic medical kits to provide immediate aid in overdose and medical emergencies, highlighting organisational challenges and the importance of training and policy. Patrol officers are…
Persistent blood sugar levels around 200 mg/dL despite metformin do not necessarily indicate drug failure, emphasising the need for diabetes assessment and possible treatment adjustments, according to experts. If blood sugar remains around 200 mg/dL despite taking metformin, it does…
A systematic review in Sports Medicine – Open reveals that with careful planning and modern glucose monitoring, individuals with type 1 diabetes can participate safely in endurance events such as marathons and ultra-marathons, challenging previous assumptions about risks and management.…
Clinicians emphasise that knowledge of pump algorithms is crucial for effective diabetes management with automated insulin delivery systems, as new device options and algorithm types offer personalised care but require understanding of their unique features. At a recent Association of…
A new study from Kaunas University of Technology reveals advanced AI models that could revolutionise glucose monitoring by predicting swings up to an hour in advance, offering hope for improved diabetes care in Europe’s rising diabetes landscape. Type 1 diabetes…
Use of GLP-1 weight-loss medicines in the United States has reached unprecedented levels, signalling a rapid shift in public approaches to weight management amid growing mainstream acceptance and market expansion. Use of GLP-1 weight-loss medicines has climbed to a record…
